![Daniel Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Simon
Corporate Officer/Principal at
IDEAYA BIOSCIENCES, INC.
Profile
Daniel A. Simon is Chief Business Officer at IDEAYA Biosciences, Inc. since 2024.
Formerly, Chief Business Officer at Revolution Medicines, Inc. from 2022 to 2024.
Senior VP-Biopharma Business Development at Guardant Health, Inc. from 2015 to 2022.
Education includes graduate studies at the University of Cambridge and an MBA from The Wharton School of the University of Pennsylvania.
Daniel Simon active positions
| Companies | Position | Start |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | 2024-07-31 |
Former positions of Daniel Simon
| Companies | Position | End |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Corporate Officer/Principal | 2023-12-31 |
| GUARDANT HEALTH, INC. | Corporate Officer/Principal | 2021-12-31 |
Training of Daniel Simon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Guardant Health, Inc.
 Guardant Health, Inc. Medical/Nursing ServicesHealth Services Develops diagnostic technologies to improve cancer management | Health Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Daniel Simon
